AYTU BIOPHARMA, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2022
Total Assets: $137.6M
Liabilities Breakdown FY2022
Total Liabilities: $93.3M
Asset Breakdown
Total Assets: $137.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.4M | 14.1% |
| Accounts Receivable | $21.7M | 15.8% |
| Inventory | $10.8M | 7.9% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $70.6M | 51.3% |
| Other Assets | $15.1M | 11.0% |
Liabilities Breakdown
Total Liabilities: $93.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $15.0M | 16.1% |
| Other Liabilities | $78.3M | 83.9% |